Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 8/20 | 0.48 |
| ▸ | FAAH | O00519 | 4/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | GMNN | O75496 | 1/20 | 0.38 |
| ▸ | THPO | P40225 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | FDPS | P14324 | 2/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4309956 | 0.98 | MGLL (0.52) | MGLLFAAHPTGS1PTGS2LMNA | |
| SCHEMBL4301460 | 0.98 | MGLL (0.52) | MGLLFAAHPTGS1PTGS2LMNA | |
| SCHEMBL4307621 | 0.98 | MGLL (0.52) | MGLLFAAHPTGS1PTGS2LMNA | |
| SCHEMBL17065231 | 0.98 | MGLL (0.52) | MGLLFAAHPTGS1PTGS2LMNA | |
| SCHEMBL4302889 | 0.98 | MGLL (0.52) | MGLLFAAHPTGS1PTGS2LMNA | |
| SCHEMBL4309970 | 0.98 | MGLL (0.52) | MGLLFAAHPTGS1PTGS2LMNA | |
| SCHEMBL4306818 | 0.98 | MGLL (0.52) | MGLLFAAHPTGS1PTGS2LMNA | |
| SCHEMBL4304987 | 0.98 | MGLL (0.52) | MGLLFAAHPTGS1PTGS2LMNA | |
| SCHEMBL7044109 | 0.98 | MGLL (0.52) | MGLLFAAHPTGS1PTGS2LMNA | |
| SCHEMBL4304357 | 0.98 | MGLL (0.52) | MGLLFAAHPTGS1PTGS2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5649 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4689130-A2 | METHODS AND COMPOSITIONS FOR ENHANCED EXPRESSION OF EXOGENOUS CASEINS IN TRANSGENIC PLANTS | Mozza Foods Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| US-12472267-B2 | Compositions containing nucleic acid nanoparticles with modular functionality | Sixfold Bioscience Ltd. (GB) | 2025-11-18 | — | — | US | claimed |
| WO-2025235971-A1 | METHODS FOR DETECTING DNA SEQUENCE VARIATION IN THICK TISSUE SECTIONS | THE JOHNS HOPKINS UNIVERSITY (US) | 2025-11-13 | — | — | WO | claimed |
| US-20250295745-A1 | CROSS-LINKED TUMOR LYSATE SPHERICAL NUCLEIC ACIDS AS CANCER VACCINES | NORTHWESTERN UNIVERSITY | 2025-09-25 | — | — | US | claimed |
| EP-4615969-A1 | METHODS FOR DETECTING RNA AND MOLECULAR ANALYSIS IN THICK TISSUE SECTIONS | The Johns Hopkins University (US) | 2025-09-17 | — | — | EP | claimed |
| EP-4541374-A2 | DEFINED MULTI-CONJUGATE OLIGONUCLEOTIDES | Mpeg LA, L.l.c. (US) | 2025-04-23 | — | — | EP | claimed |
| WO-2025054602-A1 | PROTEIN FOR THE SEROLOGICAL DETECTION OF STREPTOCOCCUS EQUI SUBSPECIES EQUI EXPOSURE OR INFECTION | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2025-03-13 | — | — | WO | claimed |
| WO-2024206469-A2 | METHODS AND COMPOSITIONS FOR ENHANCED EXPRESSION OF EXOGENOUS CASEINS IN TRANSGENIC PLANTS | Mozza Foods Inc. (US) | 2024-10-03 | — | — | WO | claimed |
| US-20240191240-A1 | DEFINED MULTI-CONJUGATES OLIGONUCLEOTIDES | MPEG LA L L C (US) | 2024-06-13 | — | — | US | claimed |
| WO-2024103007-A1 | METHODS FOR DETECTING RNA AND MOLECULAR ANALYSIS IN THICK TISSUE SECTIONS | THE JOHNS HOPKINS UNIVERSITY (US) | 2024-05-16 | — | — | WO | claimed |
| US-5534254-A | Biosynthetic binding proteins for immuno-targeting | CHIRON CORPORATION (US) | 1996-07-09 | — | — | US | claimed |
| EP-0604624-A1 | MULTIMERIC FORMS OF HUMAN RHINOVIRUS RECEPTOR PROTEIN | Bayer Corporation (US) | 1994-07-06 | — | — | EP | claimed |
| WO-1994000485-A1 | MULTIMERIC FORMS OF HUMAN RHINOVIRUS RECEPTOR PROTEIN | MILES INC. (US) | 1994-01-06 | — | — | WO | claimed |
| EP-0270937-B1 | STABLE IMMOBILIZED HAPTEN REAGENT FOR USE IN HETEROGENEOUS IMMUNOMETRIC ASSAYS | MILES INC. (US) | 1992-09-23 | — | — | EP | claimed |
| EP-0502131-A1 | PRODUCTION OF MULTIMERIC GLYCOPROTEINS THROUGH CHEMICAL COUPLING | BIOGEN, INC. (US) | 1992-09-09 | — | — | EP | claimed |
| WO-1992013562-A1 | AN IMMUNOTOXIN WITH IN VIVO T CELL SUPPRESSANT ACTIVITY | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, U.S. DEPARTMENT OF COMMERCE (US) | 1992-08-20 | — | — | WO | claimed |
| WO-1992005188-A1 | PRODUCTION OF MULTIMERIC GLYCOPROTEINS THROUGH CHEMICAL COUPLING | BIOGEN, INC. (US) | 1992-04-02 | — | — | WO | claimed |
| EP-0468257-A1 | Multimeric form of human rhinovirus receptor protein | Bayer Corporation (US) | 1992-01-29 | — | — | EP | claimed |
| US-4822747-A | STABILIZATION IN AQUEOUS SOLUTION | MILES INC. (US) | 1989-04-18 | — | — | US | claimed |
| EP-0270937-A2 | Stable immobilized hapten reagent for use in heterogeneous immunometric assays | MILES INC. (US) | 1988-06-15 | — | — | EP | claimed |